Product Description
| Brand | Snibe |
| Sample Type | Serum |
| Pack Size | 50T |
| CAT No. | 130617505M |
| Application | Autoimmune |
The kit has been designed for the quantitative determination of IgG antibodies against Scl-70 (DNA topoisomerase I) in human serum or plasma. The method can be used for samples within a measuring range of 0.1-200 U/mL. The test is performed on fully automated MAGLUMI chemiluminescence immunoassay (CLIA) analyzers, including MAGLUMI 800, MAGLUMI X8, and other MAGLUMI models such as MAGLUMI 1000, MAGLUMI 2000, MAGLUMI 2000 Plus, and MAGLUMI 4000.Advanced Detection for Systemic Sclerosis DiagnosisMAGLUMI Anti-Scl-70 IgG (CLIA) delivers high sensitivity and specificity for the detection of Anti-Scl-70 antibodies, essential in diagnosing systemic sclerosis. Its compatibility with MAGLUMI analyzers streamlines testing processes in clinical laboratories, supporting clinicians with timely and accurate results. The technology enhances workflow efficiency and enables laboratories to deliver better patient outcomes.
Chemiluminescence Immunoassay for Reliable ResultsHarnessing sophisticated chemiluminescence immunoassay (CLIA) technology, this reagent ensures consistent performance and minimizes error potential. Laboratories benefit from rapid turnaround times, reproducibility, and easy integration into existing MAGLUMI platforms, facilitating the management of autoimmune diagnostics with confidence.
FAQ's of MAGLUMI Anti-Scl-70 IgG (CLIA):
Q: How should MAGLUMI Anti-Scl-70 IgG (CLIA) reagents be stored?
A: MAGLUMI Anti-Scl-70 IgG (CLIA) reagents must be stored at a temperature between 2 and 8 degrees Celsius to preserve their stability and effectiveness. Do not freeze the reagents or expose them to direct sunlight.
Q: What equipment is required to use MAGLUMI Anti-Scl-70 IgG (CLIA)?
A: The reagents are designed exclusively for use with MAGLUMI CLIA analyzers, which are chemiluminescence immunoassay instruments compatible with these specific assays.
Q: When is the MAGLUMI Anti-Scl-70 IgG (CLIA) assay most beneficial in a laboratory setting?
A: The assay is most beneficial when rapid and accurate detection of Anti-Scl-70 IgG is required, such as in the investigation of autoimmune disorders like systemic sclerosis.
Q: Where can laboratories in India purchase MAGLUMI Anti-Scl-70 IgG (CLIA) reagents?
A: These reagents are available through authorized dealers, distributors, exporters, manufacturers, suppliers, traders, and wholesalers across India.
Q: What is the process for running the MAGLUMI Anti-Scl-70 IgG (CLIA) assay?
A: Begin by loading the reagent onto the MAGLUMI analyzer according to the manufacturer's instructions. The analyzer automates the chemiluminescence immunoassay process, and results are generated in real time.
Q: How does the use of CLIA technology in MAGLUMI Anti-Scl-70 IgG benefit laboratories?
A: The CLIA technology provides high sensitivity and specificity, reduces manual intervention, and ensures reproducible results, supporting reliable autoimmune diagnostics.